Accession Number: | 0001209191-19-058570 |
Date: | 2019-12-01 |
Issuer: | CRISPR THERAPEUTICS AG (CRSP) |
Original Submission Date: |
KULKARNI SAMARTH
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON SHARES | 2019-12-01 | F | 741 | d | $71.65 | 164,320 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | on december 1, 2017, the reporting person was granted 26,667 restricted stock units. on december 1, 2019, 1,667 restricted stock units vested, and the reporting person forfeited 741 common shares to the issuer to satisfy tax withholding obligations. |